🔗 Share this article

Texas Attorney General Paxton is filing a lawsuit against the manufacturers of acetaminophen, alleging the companies withheld potential risks that the drug created to children's cognitive development.

The lawsuit follows a month after Former President Trump promoted an unproven link between consuming Tylenol - referred to as paracetamol - during pregnancy and autism in children.

Paxton is filing suit against Johnson & Johnson, which once produced the medication, the sole analgesic suggested for women during pregnancy, and Kenvue, which now manufacturers it.

In a official comment, he said they "misled consumers by making money from suffering and pushing pills ignoring the risks."

Kenvue says there is no credible evidence tying acetaminophen to autism spectrum disorder.

"These manufacturers deceived for years, deliberately risking millions to boost earnings," the attorney general, from the Republican party, stated.

The company said in a statement that it was "deeply concerned by the perpetuation of misinformation on the safety of acetaminophen and the potential impact that could have on the welfare of women and children in America."

On its online platform, Kenvue also stated it had "consistently assessed the pertinent research and there is lacking reliable evidence that indicates a proven link between taking paracetamol and autism."

Groups acting on behalf of doctors and healthcare providers agree.

The American College of Obstetricians and Gynecologists has stated paracetamol - the key substance in acetaminophen - is one of the few options for pregnant women to treat pain and fever, which can create serious health risks if not addressed.

"In over twenty years of investigation on the use of acetaminophen in gestation, zero credible investigations has definitively established that the consumption of acetaminophen in any stage of gestation causes brain development issues in offspring," the organization stated.

This legal action references recent announcements from the former administration in claiming the drug is reportedly hazardous.

Recently, the former president caused concern from public health officials when he advised women during pregnancy to "resist strongly" not to take Tylenol when unwell.

The FDA then published an announcement that medical professionals should consider limiting the usage of Tylenol, while also declaring that "a causal relationship" between the medication and autism in young ones has remains unverified.

Health Secretary Robert F Kennedy Jr, who oversees the Food and Drug Administration, had vowed in April to initiate "comprehensive study program" that would identify the source of autism in a short period.

But experts cautioned that identifying a sole reason of autism - believed by scientists to be the outcome of a intricate combination of genetic and surrounding conditions - would not be simple.

Autism is a type of lifelong neurodivergence and disability that affects how individuals encounter and relate to the environment, and is identified using physician assessments.

In his court filing, Paxton - aligned with the former president who is running for the Senate - alleges Kenvue and J&J "willfully ignored and sought to suppress the evidence" around paracetamol and autism spectrum disorder.

The case attempts to require the corporations "eliminate any marketing or advertising" that asserts acetaminophen is safe for expectant mothers.

The court case echoes the complaints of a group of parents of young ones with autism and attention deficit hyperactivity disorder who filed suit against the producers of acetaminophen in recently.

The court dismissed the lawsuit, saying research from the family's specialists was lacking definitive proof.